Contracts & Pricing February 27, 2023 FDA Set to Apply Orphan-Drug Exclusivity, 2022 Employer Health Benefits Survey... 5 Minute Read Updates on two significant regulatory topics, including the FDA decision on orphan-drug exclusivity regulations and highlights from the Kaiser Family Foundation 2022 Employer Benefits Survey.
Contracts & Pricing January 31, 2023 Inflation Reduction Act Impact on R&D, OIG Studies on Average Sales... 6 Minute Read Updates on four significant regulatory topics, including the inflation reduction act impact on research and development, Office of Inspector General studies on Average Sales Price, and a shift of...
Contracts & Pricing December 20, 2022 Value-Based Purchasing, Interchangeability in Biosimilars, Year End 2022 Roundup 5 Minute Read Updates on two significant regulatory topics, including value-based purchasing, interchangeabilty with biosimilars, and an end of 2022 roundup.
Contracts & Pricing December 15, 2022 2022 Trends in State Pricing Transparency Reporting 3 Minute Read This is the first in a two-part blog series covering the ever-changing requirements by states as well as 2022 trends in Pricing Transparency Reporting.
Contracts & Pricing November 23, 2022 Consumer Price Index, Pricing Transparency Updates, and the Impact of Digital... 5 Minute Read Regulatory and legal updates on three significant regulatory topics, including consumer price index, pricing transparency updates, and the impact of digital pharmacies.
Contracts & Pricing October 27, 2022 Stacking Discounts for Best Price, PHS & 340B, HHS Ruling 3 Minute Read Regulatory and legal updates on three significant regulatory topics, including stacking of discounts for best price, PHS and 340B.
Contracts & Pricing September 27, 2022 FSS Public Law, US Territory Inclusion, and Branded Prescription Fee Invoice 4 Minute Read Regulatory and legal updates on four significant regulatory topics, including the Inflation Reduction Act and FSS Public Law updates.
Contracts & Pricing August 29, 2022 The Impact of the Inflation Reduction Act on the Pharmaceutical Industry 4 Minute Read Explore some of the key provisions and timelines of the Inflation Reduction Act for their impact on pharmaceutical manufacturers government pricing and GTN strategies.
Contracts & Pricing August 19, 2022 NDC Format Proposal, Focus on PBMs, False Claims Act 4 Minute Read August's market update is a legislative review of the NDC formal proposal, FTC investigation of PBMs, and the False Claims Act.
